Skip to main content
MedPacto, Inc. logo

MedPacto, Inc. — Investor Relations & Filings

Ticker · 235980 ISIN · KR7235980000 KO Manufacturing
Open in API
Filings indexed 262 across all filing types
Latest filing 2024-01-10 Report Publication Anno…
Country KR South Korea
Listing KO 235980

About MedPacto, Inc.

http://www.medpacto.com/eng/

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of first-in-class therapies. The company leverages a biomarker-driven and genome-based platform to create personalized treatments, aiming to advance precision medicine. Its primary therapeutic areas include oncology and autoimmune diseases, with pipeline expansion into metabolic and bone joint disorders. MedPacto's research focuses on novel mechanisms, such as modulating the tumor microenvironment, to address incurable diseases and overcome the limitations of existing treatments.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, time, location, purpose, and agenda for the presentation. Since this is an announcement of an event rather than the presentation slides themselves, and it fits the criteria for a regulatory notification of an IR activity, it is classified as a Regulatory Filing (RNS).
2024-01-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service (국민연금공단) regarding their stake in MedPacto (메드팩토). This is a standard regulatory filing in South Korea used to disclose when an entity's shareholding crosses specific thresholds (typically 5% or changes of 1% or more). In the provided classification schema, 'Major Shareholding Notification' (MRQ) is the correct category for filings that report changes in significant share ownership levels.
2024-01-08 Korean
투자판단관련주요경영사항(임상시험계획승인신청등결정)(전이성 결장직장암 환자 대상 백토서팁 키트루다 병용 요법 제2b/3상 미국 FDA 임상 시험 계획 승인)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (MedPacto) regarding the approval of a clinical trial (Phase 2b/3) by the US FDA. It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) required by the Korea Exchange (KRX). Since it details a specific regulatory event (clinical trial approval) and does not fit into categories like financial reports, dividends, or M&A, it is classified as a general regulatory filing.
2024-01-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of a specific individual (Kim Seong-jin, CEO) in MedPacto. This type of filing is a standard regulatory requirement for insider trading or changes in ownership by directors/executives, which corresponds to the 'Director's Dealing' category.
2023-12-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (buying/selling) of an executive (Kang Dong Woo) of MedPacto. This type of filing is a standard regulatory requirement for insider trading/shareholding disclosures, which corresponds to the 'Director's Dealing' category.
2023-12-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and the Korea Exchange. This is a standard regulatory filing in South Korea used to disclose insider transactions and changes in share ownership by company directors or major shareholders. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS) as it reports personal share transactions and ownership changes by an executive (Kim Min Woo).
2023-12-22 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.